A Comprehensive Clinical Assessment of the LumiraDx International Normalized Ratio (INR) Assay for Point-of-Care Monitoring in Anticoagulation Therapy
Riffat Munir, Elise Schapkaitz, Lara Noble, Sakina Loonat, Melanie McCree, Nazeer Ali, Barry Jacobson, Wendy Susan Stevens, Lesley Erica Scott, Gerald J Kost · 2024
Read A Comprehensive Clinical Assessment of the LumiraDx International Normalized Ratio (INR) Assay for Point-of-Care Monitoring in Anticoagulation Therapy by Riffat Munir, Elise Schapkaitz, Lara Noble, Sakina Loonat, Melanie McCree, Nazeer Ali, Barry Jacobson, Wendy Susan Stevens, Lesley Erica Scott, Gerald J Kost (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11639838.txt.
Description
Riffat Munir and co-authors test a bedside device that measures blood thinning levels for patients on anticoagulant drugs, at two Johannesburg hospitals in a 2024 study. The standard check needs a central lab, which can delay dose choices, especially far from big centers. A quick finger-prick test at the point of care could close that gap.
The device matched lab results well overall, with tight precision on control samples and a small average bias. Readings drifted upward at high values, though, so the authors advise confirming very high bedside results in the lab. They judge the test fit for faster, patient-centered monitoring in clinics like theirs.
Catalog record
| CREATOR | Riffat Munir, Elise Schapkaitz, Lara Noble, Sakina Loonat, Melanie McCree, Nazeer Ali, Barry Jacobson, Wendy Susan Stevens, Lesley Erica Scott, Gerald J Kost |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |